2023 Form 5500 filing — Intercept Pharma 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241210145451NAL0010335297001) for Intercept Pharma 401(K) Plan, reported by Intercept Pharmaceuticals, Inc. under EIN 22-3868459 and plan number 001. It reports 580 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$46.2MReported net assets$46,174,520
Participants580
Provider compensation$94.7K3 Schedule C row(s)$94,727
Schedules filedSchedule H, Schedule CLoaded schedules
EFAST2 acknowledgement
20241210145451NAL0010335297001
Plan sponsor
Intercept Pharmaceuticals, Inc.
EIN
22-3868459
Plan number
001
Location
Morristown, NJ
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule H · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$46.2M total assets
Net assets$46.2MLiabilities$0
Money in vs. money out
Total income / additions$15.9M
Total expenses$9.6M
Benefits paid / distributions$9.4M
Contributions
Employer$3M
Participant$5.7M
Full reported line items
Total assets (EOY)
$46,174,520
Total liabilities (EOY)
$0
Net assets (EOY)
$46,174,520
Employer contributions
$2,984,043
Participant contributions
$5,657,426
Total income / additions
$15,867,301
Benefits paid
$9,442,805
Administrative expenses
$137,955
Total expenses
$9,586,213
Net increase / (decrease)
$6,281,088
Schedule C

Reported service provider compensation

Compensation reported on the 2023 filing, ranked by reported total.

  1. 1
    INVESTMENT ADVISOR · Direct $86.2K
  2. 2
    RECORDKEEPER · Direct $6.5K · Indirect $0
  3. 3
    INVESTMENT MGMT · Direct $2K

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241210145451NAL0010335297001 cover?
It is the 2023 Form 5500 filing for Intercept Pharma 401(K) Plan, reported by Intercept Pharmaceuticals, Inc. (EIN 22-3868459).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

Related Form 5500 pages